Cargando…
Maternal Phthalates Exposure and Blood Pressure during and after Pregnancy in the PROGRESS Study
BACKGROUND: Phthalate exposure is ubiquitous and may affect biological pathways related to regulators of blood pressure. Given the profound changes in vasculature during pregnancy, pregnant women may be particularly susceptible to the potential effects of phthalates on blood pressure. OBJECTIVES: We...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Environmental Health Perspectives
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693773/ https://www.ncbi.nlm.nih.gov/pubmed/34935432 http://dx.doi.org/10.1289/EHP8562 |
_version_ | 1784619211605147648 |
---|---|
author | Wu, Haotian Kupsco, Allison Just, Allan Calafat, Antonia M. Oken, Emily Braun, Joseph M. Sanders, Alison P. Mercado-Garcia, Adriana Cantoral, Alejandra Pantic, Ivan Téllez-Rojo, Martha M. Wright, Robert O. Baccarelli, Andrea A. Deierlein, Andrea L. |
author_facet | Wu, Haotian Kupsco, Allison Just, Allan Calafat, Antonia M. Oken, Emily Braun, Joseph M. Sanders, Alison P. Mercado-Garcia, Adriana Cantoral, Alejandra Pantic, Ivan Téllez-Rojo, Martha M. Wright, Robert O. Baccarelli, Andrea A. Deierlein, Andrea L. |
author_sort | Wu, Haotian |
collection | PubMed |
description | BACKGROUND: Phthalate exposure is ubiquitous and may affect biological pathways related to regulators of blood pressure. Given the profound changes in vasculature during pregnancy, pregnant women may be particularly susceptible to the potential effects of phthalates on blood pressure. OBJECTIVES: We examined associations of phthalate exposure during pregnancy with maternal blood pressure trajectories from mid-pregnancy through 72 months postpartum. METHODS: Women with singleton pregnancies delivering a live birth in Mexico City were enrolled during the second trimester ([Formula: see text]). Spot urine samples from the second and third trimesters were analyzed for 15 phthalate metabolites. Blood pressure and covariate data were collected over nine visits through 72 months postpartum. We used linear, logistic, and linear mixed models; latent class growth models (LCGMs); and Bayesian kernel machine regression to estimate the relationship of urinary phthalate biomarkers with maternal blood pressure. RESULTS: As a joint mixture, phthalate biomarker concentrations during pregnancy were associated with higher blood pressure rise during mid-to-late gestation. With respect to individual biomarkers, second trimester concentrations of monobenzyl phthalate (MBzP) and di(2-ethylhexyl) phthalate biomarkers ([Formula: see text]) were associated with higher third trimester blood pressure. Two trajectory classes were identified by LCGM, characterized by increasing blood pressure through 72 months postpartum (“increase–increase”) or decreased blood pressure through 18 months postpartum with a gradual increase thereafter (“decrease–increase”). Increasing exposure to phthalate mixtures during pregnancy was associated with higher odds of being in the increase–increase class. Similar associations were observed for mono-2-ethyl-5-carboxypentyl terephthalate (MECPTP) and dibutyl phthalate ([Formula: see text]) biomarkers. When specific time periods were examined, we observed specific temporal relationships were observed for [Formula: see text] , MECPTP, MBzP, and [Formula: see text]. DISCUSSION: In our cohort of pregnant women from Mexico City, exposure to phthalates and phthalate biomarkers was associated with higher blood pressure during late pregnancy, as well as with long-term changes in blood pressure trajectories. https://doi.org/10.1289/EHP8562 |
format | Online Article Text |
id | pubmed-8693773 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Environmental Health Perspectives |
record_format | MEDLINE/PubMed |
spelling | pubmed-86937732021-12-23 Maternal Phthalates Exposure and Blood Pressure during and after Pregnancy in the PROGRESS Study Wu, Haotian Kupsco, Allison Just, Allan Calafat, Antonia M. Oken, Emily Braun, Joseph M. Sanders, Alison P. Mercado-Garcia, Adriana Cantoral, Alejandra Pantic, Ivan Téllez-Rojo, Martha M. Wright, Robert O. Baccarelli, Andrea A. Deierlein, Andrea L. Environ Health Perspect Research BACKGROUND: Phthalate exposure is ubiquitous and may affect biological pathways related to regulators of blood pressure. Given the profound changes in vasculature during pregnancy, pregnant women may be particularly susceptible to the potential effects of phthalates on blood pressure. OBJECTIVES: We examined associations of phthalate exposure during pregnancy with maternal blood pressure trajectories from mid-pregnancy through 72 months postpartum. METHODS: Women with singleton pregnancies delivering a live birth in Mexico City were enrolled during the second trimester ([Formula: see text]). Spot urine samples from the second and third trimesters were analyzed for 15 phthalate metabolites. Blood pressure and covariate data were collected over nine visits through 72 months postpartum. We used linear, logistic, and linear mixed models; latent class growth models (LCGMs); and Bayesian kernel machine regression to estimate the relationship of urinary phthalate biomarkers with maternal blood pressure. RESULTS: As a joint mixture, phthalate biomarker concentrations during pregnancy were associated with higher blood pressure rise during mid-to-late gestation. With respect to individual biomarkers, second trimester concentrations of monobenzyl phthalate (MBzP) and di(2-ethylhexyl) phthalate biomarkers ([Formula: see text]) were associated with higher third trimester blood pressure. Two trajectory classes were identified by LCGM, characterized by increasing blood pressure through 72 months postpartum (“increase–increase”) or decreased blood pressure through 18 months postpartum with a gradual increase thereafter (“decrease–increase”). Increasing exposure to phthalate mixtures during pregnancy was associated with higher odds of being in the increase–increase class. Similar associations were observed for mono-2-ethyl-5-carboxypentyl terephthalate (MECPTP) and dibutyl phthalate ([Formula: see text]) biomarkers. When specific time periods were examined, we observed specific temporal relationships were observed for [Formula: see text] , MECPTP, MBzP, and [Formula: see text]. DISCUSSION: In our cohort of pregnant women from Mexico City, exposure to phthalates and phthalate biomarkers was associated with higher blood pressure during late pregnancy, as well as with long-term changes in blood pressure trajectories. https://doi.org/10.1289/EHP8562 Environmental Health Perspectives 2021-12-22 /pmc/articles/PMC8693773/ /pubmed/34935432 http://dx.doi.org/10.1289/EHP8562 Text en https://ehp.niehs.nih.gov/about-ehp/licenseEHP is an open-access journal published with support from the National Institute of Environmental Health Sciences, National Institutes of Health. All content is public domain unless otherwise noted. |
spellingShingle | Research Wu, Haotian Kupsco, Allison Just, Allan Calafat, Antonia M. Oken, Emily Braun, Joseph M. Sanders, Alison P. Mercado-Garcia, Adriana Cantoral, Alejandra Pantic, Ivan Téllez-Rojo, Martha M. Wright, Robert O. Baccarelli, Andrea A. Deierlein, Andrea L. Maternal Phthalates Exposure and Blood Pressure during and after Pregnancy in the PROGRESS Study |
title | Maternal Phthalates Exposure and Blood Pressure during and after Pregnancy in the PROGRESS Study |
title_full | Maternal Phthalates Exposure and Blood Pressure during and after Pregnancy in the PROGRESS Study |
title_fullStr | Maternal Phthalates Exposure and Blood Pressure during and after Pregnancy in the PROGRESS Study |
title_full_unstemmed | Maternal Phthalates Exposure and Blood Pressure during and after Pregnancy in the PROGRESS Study |
title_short | Maternal Phthalates Exposure and Blood Pressure during and after Pregnancy in the PROGRESS Study |
title_sort | maternal phthalates exposure and blood pressure during and after pregnancy in the progress study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693773/ https://www.ncbi.nlm.nih.gov/pubmed/34935432 http://dx.doi.org/10.1289/EHP8562 |
work_keys_str_mv | AT wuhaotian maternalphthalatesexposureandbloodpressureduringandafterpregnancyintheprogressstudy AT kupscoallison maternalphthalatesexposureandbloodpressureduringandafterpregnancyintheprogressstudy AT justallan maternalphthalatesexposureandbloodpressureduringandafterpregnancyintheprogressstudy AT calafatantoniam maternalphthalatesexposureandbloodpressureduringandafterpregnancyintheprogressstudy AT okenemily maternalphthalatesexposureandbloodpressureduringandafterpregnancyintheprogressstudy AT braunjosephm maternalphthalatesexposureandbloodpressureduringandafterpregnancyintheprogressstudy AT sandersalisonp maternalphthalatesexposureandbloodpressureduringandafterpregnancyintheprogressstudy AT mercadogarciaadriana maternalphthalatesexposureandbloodpressureduringandafterpregnancyintheprogressstudy AT cantoralalejandra maternalphthalatesexposureandbloodpressureduringandafterpregnancyintheprogressstudy AT panticivan maternalphthalatesexposureandbloodpressureduringandafterpregnancyintheprogressstudy AT tellezrojomartham maternalphthalatesexposureandbloodpressureduringandafterpregnancyintheprogressstudy AT wrightroberto maternalphthalatesexposureandbloodpressureduringandafterpregnancyintheprogressstudy AT baccarelliandreaa maternalphthalatesexposureandbloodpressureduringandafterpregnancyintheprogressstudy AT deierleinandreal maternalphthalatesexposureandbloodpressureduringandafterpregnancyintheprogressstudy |